Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphoma.

Koji KatoShinichi MakitaHideki GotoJunya KandaNobuharu FujiiKazuyuki ShimadaKoichi AkashiKoji IzutsuTakanori TeshimaNatsuko FukudaTokuhito SumitaniHiroyuki SumiShinji ShimizuYasuyuki KakuraiKenji YoshikawaKensei TobinaiNoriko UsuiKiyohiko Hatake

Published in: International journal of clinical oncology (2021)

JapicCTI-183914.

Keyphrases

diffuse large b cell lymphoma
open label
acute lymphoblastic leukemia
acute myeloid leukemia
multiple myeloma
hodgkin lymphoma
double blind
placebo controlled
study protocol